Tag-Archive for ◊ diagnostics ◊

• Friday, May 31st, 2013

Advances in 3D and 4D ultrasound technology now offer capabilities ranging from better visualization of congenital birth defects to dynamic, multiplanar views of the fetal heart. Along with advances on the research front, the growing availability of 3D and 4D ultrasound technology has also increased public access to these ultrasound services—increasing the potential for safety [...]

Author:
• Friday, April 15th, 2011

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that its DuraSeal(TM) Exact spine sealant has been approved by the U.S. Food and Drug Administration (FDA). DuraSeal Exact spine sealant is a new, low-swell formulation of dural sealant designed as an adjunct to suturing to repair the dura during spine surgery. The [...]

Author:
• Monday, January 10th, 2011

BEDFORD, Mass., Jan. 7, 2011 /PRNewswire/ — Hologic, Inc. (Hologic or the Company) (Nasdaq:HOLX – News), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today it has acquired Interlace Medical, Inc. (Interlace), the developer and manufacturer of the MyoSure [...]

Author:
• Monday, November 15th, 2010

BOHEMIA, NY–(Marketwire – November 12, 2010) – Highlighted Links http://www.Vycormedical.com NovaVision Vycor Medical, Inc. (OTCBB: VYCO) (www.vycormedical.com), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced the entry into a purchase agreement to acquire the assets of NovaVision, Inc., including its German subsidiary, NovaVision AG (together “NovaVision”) for an [...]

Author:
• Friday, November 05th, 2010

(RTTNews) - Celera Corp. (CRA: News ) Wednesday reported a wider loss for the third quarter, hurt mainly by lower revenues and a decline in gross margin. For the third quarter, net loss widened to $8.5 million or $0.10 per share from $7.4 million or $0.09 per share in the same quarter last year. For the third quarter, [...]

Author:
• Tuesday, November 02nd, 2010

RICHMOND, Va., Oct.29 /PRNewswire/ — Health Diagnostic Laboratory (HDL, Inc.) andGovernor Bob McDonnell have announced an investment of $4.2 million in HDL, Inc. operations, resulting in the creation of 213 new jobs in the City of Richmond. HDL, Inc., located in the Virginia BioTechnology Research Park, will expand its clinical laboratory, diagnostics and clinical trial services, as well as its [...]

Author:
• Sunday, October 24th, 2010

General Electric Co., the world’s biggest maker of medical-imaging equipment, agreed to buy cancer diagnostics company Clarient Inc. in a deal valued at about $580 million, speeding its expansion into tailored tests. A tender offer will begin at $5 for each common share and $20 for each preferred share of Aliso Viejo, California-based Clarient, the companies [...]

Author:
• Wednesday, October 13th, 2010

A number of new technologies and surgical techniques promise to “personalize” orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During “Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies,” prominent orthopedic researchers will discuss how innovative [...]

Author:
• Monday, September 20th, 2010

Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT), announced its schedule of events for Transcatheter Cardiovascular Therapeutics (TCT) 2010, which takes place Sept. 21-25 in Washington, D.C. The conference will prominently feature new data on the Resolute drug-eluting stent (DES), including the primary endpoint of [...]

Author:
• Thursday, February 18th, 2010

VTT Technical Research Centre of Finland has developed a method for analysing MR images in just a few minutes when diagnosingAlzheimer’s disease. The accuracy of the analysis is comparable to manual measurements made by skilled professionals, which are currently considered the most reliable method for diagnosing Alzheimer’s disease. The accurate and rapid analysis method is [...]